A 3 item screening instrument had moderate sensitivity and specificity for detecting migraine headachesA self-administered screener for migraine in primary care: The ID MigraineTM validation study.

Chessman, Alexander W MD (commentator)
Lipton, RB
Dodick, D
Sadovsky, R
et al,

Medical University of South Carolina Charleston, South Carolina, USA

Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine(TM) validation study. Neurology 2003; 61: 375–82.LiptonRBDodickDSadovskyRet alA self-administered screener for migraine in primary care: The ID MigraineTM validation study.Neurology200361375-82Q In an outpatient primary care setting, what is the accuracy of a brief screening instrument (developed from the International Headache Society [IHS] criteria for migraine) that uses self report for detecting migraine headaches?

For correspondence: Dr R B Lipton, Albert Einstein College of Medicine, New York, NY, USA. [email protected]

Source of funding: Pfizer Inc.

Evidence Based Medicine 9(2):p 56, April 2004.

Clinical impact ratings GP/FP/Primary care ★★★★★★☆